Jude Onyia Net Worth & Insider Trades
Jude Onyia - Chief Scientific Officer, Neurocrine Biosciences Inc
What is Jude Onyia's Net Worth?
The current estimated net worth of Neurocrine Biosciences Inc's Chief Scientific Officer, Jude Onyia, is estimated to be about $984.9K . Jude Onyia owns about 6,525 units of Neurocrine Biosciences Inc common stock. In the last 2 years at Neurocrine Biosciences Inc, Jude Onyia has sold an estimated value of $758.99K worth.
What is Jude Onyia's Past Insider Trading?
Jude Onyia's largest sale order was 4,508 units , worth over $461.17K on February 8, 2023. In total, Jude Onyia has made about 6 transactions over 2 years of their time at Neurocrine Biosciences Inc. Jude Onyia usually trades in February, with the busiest year in 2023.
Jude Onyia
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Jude Onyia's' Mailing Address?
- Mailing address is C/o Neurocrine Biosciences, Inc. 12780 el Camino Real San Diego CA 92130 CA
Neurocrine Biosciences Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Stock Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Kevin C. Gorman, Ph.D. | 2018 | $675,000 | $425,250 | $4,486,852 | $2,998,832 | $47,045 | $8,632,979 |
| Kevin C. Gorman, Ph.D. | 2019 | $725,000 | $667,000 | $6,000,525 | $2,000,071 | $58,230 | $9,450,826 |
| Kevin C. Gorman, Ph.D. | 2020 | $775,000 | $542,500 | $7,124,633 | $5,375,188 | $63,311 | $13,880,632 |
| Matthew C. Abernethy | 2018 | $420,000 | $199,500 | - | $1,996,506 | $69,741 | $2,685,747 |
| Matthew C. Abernethy | 2019 | $495,600 | $284,970 | $3,750,345 | $1,250,035 | $42,170 | $5,823,120 |
| Matthew C. Abernethy | 2020 | $545,200 | $190,820 | $2,999,869 | $2,500,266 | $45,021 | $6,281,176 |
| Eric Benevich | 2018 | $432,600 | $205,485 | $1,496,335 | $1,499,417 | $38,768 | $3,672,605 |
| Eric Benevich | 2019 | $467,200 | $280,320 | $3,750,345 | $1,250,035 | $45,547 | $5,793,447 |
| Eric Benevich | 2020 | $499,900 | $199,960 | $2,999,869 | $3,000,257 | $48,974 | $6,748,960 |
| Kyle W. Gano, Ph.D. | 2018 | $403,100 | $191,473 | $1,309,024 | $2,656,575 | $8,069 | $4,568,241 |
| Kyle W. Gano, Ph.D. | 2019 | $443,400 | $266,040 | $3,000,285 | $1,000,076 | $16,171 | $4,725,972 |
| Kyle W. Gano, Ph.D. | 2020 | $487,700 | $207,273 | $3,749,799 | $2,750,210 | $16,751 | $7,211,733 |
| Eiry W. Roberts, M.D. | 2018 | $490,700 | $220,800 | $2,863,700 | $4,053,869 | $671,554 | $8,300,623 |
| Eiry W. Roberts, M.D. | 2019 | $538,200 | $309,465 | $3,000,285 | $1,000,076 | $51,889 | $4,899,915 |
| Eiry W. Roberts, M.D. | 2020 | $575,900 | $215,963 | $2,624,855 | $2,375,242 | $56,073 | $5,848,033 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm
What are Neurocrine Biosciences Inc's Past Insider Trades?
Neurocrine Biosciences Inc's most recent insider trade came on February 8, 2023 by Julie Cooke who sold 17,079 units worth $1.76M . In the last 20 years, insiders at Neurocrine Biosciences Inc have sold an estimated value of $400.2M and bought an estimated value of $67.75M worth of shares. Insider trading is most common in February, with the busiest year in 2017. The most active traders at the company are Dimitri Grigoriadis, Chief Research Officer, Gary Lyons, Director, and Haig Bozigian, Chief Development Officer .
NEUROCRINE BIOSCIENCES INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||